VOYA Investment Management’s Audentes Therapeutics, Inc BOLD Stock Holding History

VOYA Investment Management’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-22,329	Closed	-$1.34M	–	2716
2019 Q4	$1.34M	Buy	22,329 +5,535	+33%	+$208K	﹤0.01%	1296
2019 Q3	$472K	Hold	16,794	–	–	﹤0.01%	1799
2019 Q2	$636K	Buy	16,794 +1,748	+12%	+$67.2K	﹤0.01%	1618
2019 Q1	$587K	Hold	15,046	–	–	﹤0.01%	1680
2018 Q4	$321K	Buy	15,046 +2,661	+21%	+$68.7K	﹤0.01%	1985
2018 Q3	$490K	Hold	12,385	–	–	﹤0.01%	1853
2018 Q2	$473K	Buy	12,385 +4,533	+58%	+$168K	﹤0.01%	1864
2018 Q1	$236K	Buy	7,852 +1,149	+17%	+$38.9K	﹤0.01%	2240
2017 Q4	$209K	Buy	+6,703	New	+$184K	﹤0.01%	2327

VOYA Investment Management's BOLD Position: Q1 2020 in Review

VOYA Investment Management sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 22,329 shares — an estimated $1.34M sold.

VOYA Investment Management first reported a position in BOLD in Q4 2017 and held it in 9 quarters. The position peaked at $1.34M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

VOYA Investment Management reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
VOYA Investment Management sold 22,329 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $1.34M.
VOYA Investment Management first reported a position in Audentes Therapeutics, Inc in Q4 2017 and held it in 9 quarters.
VOYA Investment Management's Audentes Therapeutics, Inc position peaked at $1.34M in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on VOYA Investment Management's 13F filing for Q1 2020, filed 15 May 2020.